Spain will begin training Iraqi forces later this year to battle Islamic State fighters but has ruled out taking part in ground operations in Syria, officials have said.
Defense Minister Pedro Morenes made the announcement in Washington, where he met Friday with US Defense Secretary Chuck Hagel.
"We could be starting up by the end of this year because the whole operation is evolving fast, all the time, every day; we have to adjust our abilities and what we are offering, in response to that evolution," Morenes told reporters yesterday.
More From This Section
In Washington, Hagel and Morenes said the two allies would be cooperating on the fight against IS fighters.
Hagel and Morenes also vowed to cooperate against Ebola, which has killed more than 4,500 people mainly in West Africa.
"The two leaders discussed how each of their nations is addressing the virus, focusing on the importance of strict protocols to protect the American and Spanish people," Pentagon spokesman Rear Admiral John Kirby said in a statement.
As such, under a 1952 agreement, Spain will allow US planes to use its bases in Moron and Rota in southern Spain to facilitate the transfer of material and personnel to hard-hit West Africa, Morenes said.
But the bases will also serve American troops deployed to northern Iraq.
A global UN appeal for nearly USD 1 billion to fight the spread of the disease has so far fallen short, but a spokesman told AFP more funds were coming in daily.
Out of USD 988 million requested a month ago, the UN said yesterday that USD 385.9 million had already been given by a slew of governments and agencies, with a further USD 225.8 million promised.
Symptoms of Ebola include fever, headache, diarrhea, vomiting and in some cases bleeding.
Even if a person is infected, the virus can only be passed on once symptoms appear and only through direct contact with their bodily fluids, such as mucus, semen, saliva, vomit, stool or blood.
There is no licensed treatment or vaccine for the contagious disease, but several countries are trying to develop an effective vaccine.